Oral delivery system for methylcobalamin to treat disorders
AssigneeRevitapop
InventorSTAN KURTZ
Life of this patent
Estimating the term…
Loading patent…
AssigneeRevitapop
InventorSTAN KURTZ
Estimating the term…
A method of treating a disorder by lollipop administering methylcobalamin, with or without folinic acid by direct delivery to the trigeminal nerve. The disorders addressed are: a) attention deficit hyperactivity disorder (ADHD); b) anxiety, depression, stress and chronic stress; c) socialization problems, mood problems, behavior problems, memory problems; d) dyslexia, depth perception problems, color viewing problems, visual and auditory processing problems, light modulation problems, night vision problems; e) speech problems such as finding words, apraxia, and articulation problems, sleep regulation problems, eye or muscle movement problems; and f) chronic fatigue problems, digestion problems, sensitivity to chemicals, viral infection, inflammatory conditions such as rheumatoid arthritis, sciatica, and fibromyalgia, asthma, irritable bowel, colitis, tinnitus, migraines, nail biting, autoimmune problems. In some embodiments, the disorders that are particularly addressed are ADHD, anxiety, stress and chronic stress, and irritable bowel. A lollipop for treating a psychological or neuro-physiological disorder and method of making thereof.
A method of treating a psychological or neuro-physiological disorder, comprising administering orally a lollipop including methylcobalamin, or a pharmaceutically acceptable salt thereof, to a person in an amount sufficient to treat the disorder in the person.
A lollipop for orally treating a psychological or neurophysiological disorder, comprising methylcobalamin, or a pharmaceutically acceptable salt thereof, in an amount sufficient to treat the disorder in the person.
A method of making a lollipop for orally treating a psychological or neuro-physiological disorder comprises:
Dependencies are inferred from the claim text.